Dingal, Genrose .

HRN: 22-49-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/15/2023
CEFUROXIME 750MG (VIAL)
01/15/2023
01/22/2023
IVTT
750 Mg
Q8
AGE With Mod; T/C UTI
Waiting Final Action 
01/21/2023
CEFTRIAXONE 1G (VIAL)
01/21/2023
01/28/2023
IVTT
2g
Q24
T/c Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: